A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators

The syndrome of resistance to thyroid hormone is characterized by elevated serum free thyroid hormones, failure to suppress pituitary thyrotropin secretion, and variable peripheral refractoriness to hormone action. Here we describe a novel leucine to valine mutation in codon 454 (L454V) of the thyro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS Jg. 94; H. 1; S. 248
Hauptverfasser: Collingwood, T N, Rajanayagam, O, Adams, M, Wagner, R, Cavaillès, V, Kalkhoven, E, Matthews, C, Nystrom, E, Stenlof, K, Lindstedt, G, Tisell, L, Fletterick, R J, Parker, M G, Chatterjee, V K
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 07.01.1997
Schlagworte:
ISSN:0027-8424
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract The syndrome of resistance to thyroid hormone is characterized by elevated serum free thyroid hormones, failure to suppress pituitary thyrotropin secretion, and variable peripheral refractoriness to hormone action. Here we describe a novel leucine to valine mutation in codon 454 (L454V) of the thyroid hormone beta receptor (TR beta) in this disorder, resulting in a mutant receptor with unusual functional properties. Although the mutant protein binds ligand comparably to wild-type receptor and forms homo- and heterodimers on direct repeat, everted repeat, or palindromic thyroid response elements, its ability to activate transcription via these elements is markedly impaired. The hydrophobic leucine residue lies within an amphipathic alpha-helix at the carboxyl terminus of TR beta and the position of the homologous residue in the crystal structure of TR alpha indicates that its side chain is solvent-exposed and might interact with other proteins. We find that two putative transcriptional mediators (RIP140 and SRC-1) exhibit hormone-dependent association with wild-type TR. In comparison, the interaction of this natural mutant (L454V) and artificial mutants (L454A, E457A) with RIP140 and SRC-1 is markedly reduced. Furthermore, coexpression of SRC-1 is able to restore the transcriptional activity of the L454V mutant receptor, indicating that the interaction of this residue with accessory proteins is critical for transcriptional activation. Finally, the occurrence of the L454V mutation in resistance to thyroid hormone, together with impaired negative regulation of the thyroid-stimulating hormone alpha promoter by this mutant, suggests that the amphipathic alpha-helix also mediates hormone-dependent transcriptional inhibition, perhaps via interaction with these or other accessory factors.
AbstractList The syndrome of resistance to thyroid hormone is characterized by elevated serum free thyroid hormones, failure to suppress pituitary thyrotropin secretion, and variable peripheral refractoriness to hormone action. Here we describe a novel leucine to valine mutation in codon 454 (L454V) of the thyroid hormone beta receptor (TR beta) in this disorder, resulting in a mutant receptor with unusual functional properties. Although the mutant protein binds ligand comparably to wild-type receptor and forms homo- and heterodimers on direct repeat, everted repeat, or palindromic thyroid response elements, its ability to activate transcription via these elements is markedly impaired. The hydrophobic leucine residue lies within an amphipathic alpha-helix at the carboxyl terminus of TR beta and the position of the homologous residue in the crystal structure of TR alpha indicates that its side chain is solvent-exposed and might interact with other proteins. We find that two putative transcriptional mediators (RIP140 and SRC-1) exhibit hormone-dependent association with wild-type TR. In comparison, the interaction of this natural mutant (L454V) and artificial mutants (L454A, E457A) with RIP140 and SRC-1 is markedly reduced. Furthermore, coexpression of SRC-1 is able to restore the transcriptional activity of the L454V mutant receptor, indicating that the interaction of this residue with accessory proteins is critical for transcriptional activation. Finally, the occurrence of the L454V mutation in resistance to thyroid hormone, together with impaired negative regulation of the thyroid-stimulating hormone alpha promoter by this mutant, suggests that the amphipathic alpha-helix also mediates hormone-dependent transcriptional inhibition, perhaps via interaction with these or other accessory factors.
The syndrome of resistance to thyroid hormone is characterized by elevated serum free thyroid hormones, failure to suppress pituitary thyrotropin secretion, and variable peripheral refractoriness to hormone action. Here we describe a novel leucine to valine mutation in codon 454 (L454V) of the thyroid hormone beta receptor (TR beta) in this disorder, resulting in a mutant receptor with unusual functional properties. Although the mutant protein binds ligand comparably to wild-type receptor and forms homo- and heterodimers on direct repeat, everted repeat, or palindromic thyroid response elements, its ability to activate transcription via these elements is markedly impaired. The hydrophobic leucine residue lies within an amphipathic alpha-helix at the carboxyl terminus of TR beta and the position of the homologous residue in the crystal structure of TR alpha indicates that its side chain is solvent-exposed and might interact with other proteins. We find that two putative transcriptional mediators (RIP140 and SRC-1) exhibit hormone-dependent association with wild-type TR. In comparison, the interaction of this natural mutant (L454V) and artificial mutants (L454A, E457A) with RIP140 and SRC-1 is markedly reduced. Furthermore, coexpression of SRC-1 is able to restore the transcriptional activity of the L454V mutant receptor, indicating that the interaction of this residue with accessory proteins is critical for transcriptional activation. Finally, the occurrence of the L454V mutation in resistance to thyroid hormone, together with impaired negative regulation of the thyroid-stimulating hormone alpha promoter by this mutant, suggests that the amphipathic alpha-helix also mediates hormone-dependent transcriptional inhibition, perhaps via interaction with these or other accessory factors.The syndrome of resistance to thyroid hormone is characterized by elevated serum free thyroid hormones, failure to suppress pituitary thyrotropin secretion, and variable peripheral refractoriness to hormone action. Here we describe a novel leucine to valine mutation in codon 454 (L454V) of the thyroid hormone beta receptor (TR beta) in this disorder, resulting in a mutant receptor with unusual functional properties. Although the mutant protein binds ligand comparably to wild-type receptor and forms homo- and heterodimers on direct repeat, everted repeat, or palindromic thyroid response elements, its ability to activate transcription via these elements is markedly impaired. The hydrophobic leucine residue lies within an amphipathic alpha-helix at the carboxyl terminus of TR beta and the position of the homologous residue in the crystal structure of TR alpha indicates that its side chain is solvent-exposed and might interact with other proteins. We find that two putative transcriptional mediators (RIP140 and SRC-1) exhibit hormone-dependent association with wild-type TR. In comparison, the interaction of this natural mutant (L454V) and artificial mutants (L454A, E457A) with RIP140 and SRC-1 is markedly reduced. Furthermore, coexpression of SRC-1 is able to restore the transcriptional activity of the L454V mutant receptor, indicating that the interaction of this residue with accessory proteins is critical for transcriptional activation. Finally, the occurrence of the L454V mutation in resistance to thyroid hormone, together with impaired negative regulation of the thyroid-stimulating hormone alpha promoter by this mutant, suggests that the amphipathic alpha-helix also mediates hormone-dependent transcriptional inhibition, perhaps via interaction with these or other accessory factors.
Author Adams, M
Nystrom, E
Cavaillès, V
Tisell, L
Fletterick, R J
Matthews, C
Chatterjee, V K
Lindstedt, G
Wagner, R
Rajanayagam, O
Stenlof, K
Parker, M G
Collingwood, T N
Kalkhoven, E
Author_xml – sequence: 1
  givenname: T N
  surname: Collingwood
  fullname: Collingwood, T N
  organization: Department of Medicine, University of Cambridge, Addenbrooke's Hospital, United Kingdom
– sequence: 2
  givenname: O
  surname: Rajanayagam
  fullname: Rajanayagam, O
– sequence: 3
  givenname: M
  surname: Adams
  fullname: Adams, M
– sequence: 4
  givenname: R
  surname: Wagner
  fullname: Wagner, R
– sequence: 5
  givenname: V
  surname: Cavaillès
  fullname: Cavaillès, V
– sequence: 6
  givenname: E
  surname: Kalkhoven
  fullname: Kalkhoven, E
– sequence: 7
  givenname: C
  surname: Matthews
  fullname: Matthews, C
– sequence: 8
  givenname: E
  surname: Nystrom
  fullname: Nystrom, E
– sequence: 9
  givenname: K
  surname: Stenlof
  fullname: Stenlof, K
– sequence: 10
  givenname: G
  surname: Lindstedt
  fullname: Lindstedt, G
– sequence: 11
  givenname: L
  surname: Tisell
  fullname: Tisell, L
– sequence: 12
  givenname: R J
  surname: Fletterick
  fullname: Fletterick, R J
– sequence: 13
  givenname: M G
  surname: Parker
  fullname: Parker, M G
– sequence: 14
  givenname: V K
  surname: Chatterjee
  fullname: Chatterjee, V K
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8990194$$D View this record in MEDLINE/PubMed
BookMark eNotkD1PwzAQhj0UlVIYGZE8sSU4rlPbbFXFl1SJBebo6g_VKHGC7RT1B_C_cWmH05107_u8p7tCE997g9BtRcqK8MXD4CGWkpVVSZmYoBkhlBeCUXaJrmL8IoTIWpApmgopSSXZDP2usIc0BmhxCuAjqOT2kFzvcTem0-A8TjuT6xB6p_GuD12OxVuTAAejzJD68IhdN4ALRmd5MuHIydYfl3Z4-AftzSlBBTccdzmxM9pBNsdrdGGhjebm3Ofo8_npY_1abN5f3tarTaFqJlKhCVBBCZea2NoKJamwUCtBFAitrFyyCriSirEtLCxVREoDVvAFl7UW2TpH9yfuEPrv0cTUdC4q07bgTT_GhgsuqyWts_DuLBy3-cpmCK6DcGjOf6N_JmNz-g
CitedBy_id crossref_primary_10_1074_jbc_M212950200
crossref_primary_10_1517_14728222_4_5_665
crossref_primary_10_1074_jbc_272_47_29834
crossref_primary_10_1111_j_1440_1681_1998_tb02293_x
crossref_primary_10_1172_JCI24109
crossref_primary_10_1128_MCB_21_1_343_353_2001
crossref_primary_10_1016_j_beem_2015_07_005
crossref_primary_10_1038_nchembio_625
crossref_primary_10_1210_mend_12_12_0201
crossref_primary_10_1515_HMBCI_2010_045
crossref_primary_10_1002_pmic_200401090
crossref_primary_10_1002_jcb_1165
crossref_primary_10_1210_endo_142_2_7927
crossref_primary_10_1210_mend_14_8_0499
crossref_primary_10_1016_S1043_2760_03_00114_0
crossref_primary_10_1371_journal_pone_0054901
crossref_primary_10_1210_me_2002_0124
crossref_primary_10_1210_me_2002_0287
crossref_primary_10_1210_mend_16_7_0868
crossref_primary_10_1128_MCB_24_2_502_513_2004
crossref_primary_10_1210_me_2002_0326
crossref_primary_10_2165_00066982_200408030_00004
crossref_primary_10_1007_BF03260060
crossref_primary_10_1016_S0014_5793_99_00453_6
crossref_primary_10_1074_jbc_274_52_37483
crossref_primary_10_1210_mend_13_7_0292
crossref_primary_10_1074_jbc_273_46_30175
crossref_primary_10_1016_j_gene_2013_04_071
crossref_primary_10_1074_jbc_M407539200
crossref_primary_10_1016_S0002_9343_98_00319_2
crossref_primary_10_3389_fendo_2021_656551
crossref_primary_10_1074_jbc_275_8_5754
crossref_primary_10_3109_13816810_2012_681096
crossref_primary_10_1146_annurev_physiol_62_1_439
crossref_primary_10_1016_S0014_5793_00_01970_0
crossref_primary_10_1007_s00125_003_1037_4
crossref_primary_10_1210_mend_11_6_0003
crossref_primary_10_1126_science_280_5370_1747
crossref_primary_10_1210_en_2006_1248
crossref_primary_10_1093_emboj_cdf523
crossref_primary_10_1210_mend_16_7_0860
crossref_primary_10_1016_j_mce_2022_111679
crossref_primary_10_1210_me_2005_0068
crossref_primary_10_1101_gad_12_21_3343
crossref_primary_10_1210_en_2009_0093
crossref_primary_10_1128_MCB_17_12_6887
crossref_primary_10_1016_S0303_7207_98_00237_8
crossref_primary_10_1089_thy_2019_0019
crossref_primary_10_1007_s40291_019_00399_w
crossref_primary_10_1074_jbc_M105172200
crossref_primary_10_1128_MCB_18_11_6745
crossref_primary_10_1210_endo_139_10_6218
crossref_primary_10_1016_j_ando_2008_02_005
crossref_primary_10_1172_JCI5205
crossref_primary_10_1210_mend_15_1_0589
crossref_primary_10_1089_thy_2000_10_41
crossref_primary_10_1038_30775
crossref_primary_10_1046_j_1365_2265_2001_01033_x
crossref_primary_10_1074_jbc_274_23_16198
crossref_primary_10_1242_dev_00205
crossref_primary_10_1046_j_1365_2540_2000_00714_x
crossref_primary_10_1210_mend_14_8_0502
crossref_primary_10_1074_jbc_272_20_13060
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1073/pnas.94.1.248
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Sciences (General)
ExternalDocumentID 8990194
Genre Research Support, Non-U.S. Gov't
Journal Article
Case Reports
GrantInformation_xml – fundername: Wellcome Trust
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
123
29P
2AX
2FS
2WC
3O-
4.4
53G
5RE
5VS
85S
AACGO
AAFWJ
AANCE
ABBHK
ABOCM
ABPLY
ABPPZ
ABTLG
ABXSQ
ABZEH
ACGOD
ACHIC
ACIWK
ACKIV
ACNCT
ACPRK
ADULT
AENEX
AEUPB
AEXZC
AFFNX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AQVQM
AS~
BKOMP
CGR
CS3
CUY
CVF
D0L
DCCCD
DIK
DOOOF
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GX1
H13
HGD
HH5
HQ3
HTVGU
HYE
IPSME
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JSODD
JST
KQ8
L7B
LU7
MVM
N9A
NEJ
NHB
NPM
N~3
O9-
OK1
P-O
PNE
PQQKQ
R.V
RHF
RHI
RNA
RNS
RPM
RXW
SA0
SJN
TAE
TN5
UKR
VOH
VQA
VXZ
W8F
WH7
WHG
WOQ
WOW
X7M
XSW
Y6R
YBH
YIF
YIN
YKV
YSK
ZCA
ZCG
~02
~KM
7X8
ADQXQ
ADXHL
ID FETCH-LOGICAL-c548t-d0a282079d0f5f8c928fa5c80ca8dcf9641a7c9c44ba3f2c099eaf873795d8282
IEDL.DBID 7X8
ISICitedReferencesCount 90
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=10_1073_pnas_94_1_248&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0027-8424
IngestDate Sun Nov 09 13:04:04 EST 2025
Wed Feb 19 02:32:32 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c548t-d0a282079d0f5f8c928fa5c80ca8dcf9641a7c9c44ba3f2c099eaf873795d8282
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/19304
PMID 8990194
PQID 78791625
PQPubID 23479
ParticipantIDs proquest_miscellaneous_78791625
pubmed_primary_8990194
PublicationCentury 1900
PublicationDate 1997-01-07
PublicationDateYYYYMMDD 1997-01-07
PublicationDate_xml – month: 01
  year: 1997
  text: 1997-01-07
  day: 07
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Proceedings of the National Academy of Sciences - PNAS
PublicationTitleAlternate Proc Natl Acad Sci U S A
PublicationYear 1997
SSID ssj0009580
Score 1.8338062
Snippet The syndrome of resistance to thyroid hormone is characterized by elevated serum free thyroid hormones, failure to suppress pituitary thyrotropin secretion,...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 248
SubjectTerms Adaptor Proteins, Signal Transducing
Adult
Binding Sites
Dimerization
DNA-Binding Proteins - metabolism
Genes, Reporter
Histone Acetyltransferases
Humans
Leucine - genetics
Models, Molecular
Mutation
Nuclear Proteins - metabolism
Nuclear Receptor Coactivator 1
Nuclear Receptor Interacting Protein 1
Protein Binding
Receptors, Thyroid Hormone - genetics
Recombinant Proteins - metabolism
Syndrome
Thyroid Hormone Resistance Syndrome - genetics
Thyroid Hormones - pharmacology
Transcription Factors - metabolism
Transcription, Genetic
Transcriptional Activation
Valine - genetics
Title A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators
URI https://www.ncbi.nlm.nih.gov/pubmed/8990194
https://www.proquest.com/docview/78791625
Volume 94
WOSCitedRecordID wos10_1073_pnas_94_1_248&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV09T8MwELUKZWABClSUTw8MMLhNEwfbCAlViIoBqg6AulWuP0QHktCklfgB_G_OcSKxIAaGZEpiyz5f3vP53iF0TvuSqSiyhBshCLWGEqEpJxbgQyAts7LUKXh9ZKMRn0zEuIFu6lwYd6yy9omlo9apcnvkPTAsQDJhfJt9EFczysVWqwIaa6gZAZBxNs0m_IfkLvcJKCH4YRrSSmETbLqXJTLvCtoFgkj579iy_McMt__Xux20VWFLPPDG0EINk-yiVrV6c3xRSUxf7qGvAS4VPeHpoi4Y7vdm8fvSB-fxPMEADuH6XKRzjd8A3KaJwTNTSAxu0mTA1q-xy7IEr6mx051Y-CwJ7DZ3cVZ-aGV8C7VzghbLZBVX5GcfvQzvn-8eSFWQgSggNgXRgQSGFjChAxtbrkTIrYwVD5TkWllxVc68UJTOZGRDBejTSMtZxESsgdqFbbSeQFcPEDYA_KwFuGKAX0qAkVKpvpwZAPw20pZ10Fk90FMweBfFkIlJl_m0HuoOavu5mmZel2PKXYxP0MM_Xz1Cm16Ftk8CdoyaFla6OUEbalXM88VpaUZwH42fvgF88NfT
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+natural+transactivation+mutation+in+the+thyroid+hormone+beta+receptor%3A+impaired+interaction+with+putative+transcriptional+mediators&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Collingwood%2C+T+N&rft.au=Rajanayagam%2C+O&rft.au=Adams%2C+M&rft.au=Wagner%2C+R&rft.date=1997-01-07&rft.issn=0027-8424&rft.volume=94&rft.issue=1&rft.spage=248&rft_id=info:doi/10.1073%2Fpnas.94.1.248&rft_id=info%3Apmid%2F8990194&rft_id=info%3Apmid%2F8990194&rft.externalDocID=8990194
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0027-8424&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0027-8424&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0027-8424&client=summon